Infant colic and migraine

September 27, 2012

Infant colic appears to be more common in babies whose mothers suffers from migraines, according to a just published study by researchers at UCSF. This study looked at 154 infant-mother pairs and discovered that the risk of colic increases 2.6 times if mother suffers from migraines. Dr. Amy Gelfand, the pediatric neurologist who was the lead author concluded that infant colic could be the earliest manifestation of migraine headaches. We also know that some people who suffer from migraines report being told by their parents that as infants they had brief attacks of vomiting associated with paleness which seemingly were not related to food intake. This study confirms the old suspicion that migraines can begin from infancy. While we have many effective therapies, the true cure of migraines will come from genetic therapies, which unfortunately are decades away.

Written by
Alexander Mauskop, MD
Continue reading
May 21, 2026
Research
Your Brain Has Many Pathways, And TMS Can Now Use Them
A groundbreaking University of Iowa study shows that personalized fMRI-guided TMS can now reach and modulate the deep hippocampus — the brain’s command center for memory, emotion, and migraine — without surgery or heavy medications. By mapping each patient’s unique neural pathways, TMS delivers precise stimulation to surface “control points” that influence deep brain structures. Generic approaches barely work, but individualized targeting produces clear, measurable changes. At our headache clinic, we combine TMS and fMRI to offer this advanced, personalized treatment for migraines, depression, PTSD, anxiety, and more.
Read article
May 10, 2026
Research
Elismetrep: A Promising New Experimental Migraine Treatment
Elismetrep is a promising experimental migraine medication that targets the TRPM8 pathway rather than serotonin or CGRP. Early clinical trials suggest it may offer a new option for patients who do not respond well to current treatments.
Read article
May 6, 2026
Alternative Therapies
New Research on Brain Excitability and TMS Treatment for Migraine
New research shows how the brain dynamically regulates excitability in real time—and why this matters for transcranial magnetic stimulation (TMS) as a treatment for migraine.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe